We are Aigenpulse
Researchers use our platform to structure, share and analyse their research data, and scale repetitive tasks, eliminating the frustrations of dealing with Big Data and accelerating discovery and development of better targets and candidates using advanced machine learning technologies.
With coherently structured data assets, The Aigenpulse Platform significantly increases visibility and transparency across all R&D activity.
By bringing business closer to research, The Aigenpulse Platform allows commercial considerations to be tightly integrated within R&D.
Our mission is to combine machine learning and human expertise to facilitate the efficient creation of better drugs and making them available to more people.
Dominate your data
Imagine your data being at the heart of all the decisions you make, delivering powerful insights and propelling your drug discovery forward. Putting AI in the hands of researchers, Aigenpulse is the best choice for companies wanting to sweat every single data asset.
Our high-performance platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics which underpin scientific decision making. The platform is intuitive to use and provides an environment for powerful insight generation, which in turn leads to ground-breaking scientific discoveries. Our mission is to combine machine learning and human expertise to ensure that drug discovery becomes more successful and affordable.
Engage your ecosystem
We use powerful integrations to link to any public or external services, systems and resources. The platform easily integrates with your Electronic Lab Notebook or Laboratory Information Management System, with in-house data lakes and with public data sources such as Genomics England, UK Biobank, TRON, GTeX etc. It becomes an organisation’s one single source of truth, where all critical information is aggregated, stored and easily accessed.
Want to find out more about Aigenpulse?
Aigenpulse Ltd was founded in May 2016 and version 1 of the Aigenpulse Platform centred around Proteomics data processing.
Esteemed investor and experienced entrepreneur, Nick Cross agrees to join the Aigenpulse Board to oversee the running of the company.
The Aigenpulse London team sets up home in One Kingdom Street in Paddington Central.
Aigenpulse is nominated as a finalist for 2 business award categories at the 2018 Oxfordshire Business Awards: New Business of the Year and Innovation of the Year.
Aigenpulse moves into larger offices on Milton Park.
Following months of compliance work, Aigenpulse successfully gains accreditation to quality and information security management after an external audit.
Working at Aigenpulse
Aigenpulse is an innovative, open and dynamic company at the intersection between Life Sciences and Data Technologies. We thrive to streamline drug discovery and help our clients to become the best they can be.
To achieve our goals, we are looking to hire talented individuals that enrich our diverse team in our offices in Paddington, London and Milton Park, South Oxfordshire.
We are proud to be an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, colour, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. We provide flexible working arrangements and value a positive work-life balance. We offer a full benefits package including private healthcare and private pension.